Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,443.55 26.02 0.18%
TOPIX 1,167.09 0.50 0.04%
HANG SENG 22,760.24 64.23 0.28%

VIVUS to Present at Three Investor Conferences in February 2013



VIVUS to Present at Three Investor Conferences in February 2013

MOUNTAIN VIEW, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc.
(Nasdaq:VVUS) today announced that Timothy E. Morris, chief financial officer,
will present an overview of the company at three investment conferences during
the month of February 2013.

The conference presentation schedule is as follows:           

  Leerink Swann 2013 Global Healthcare Conference
  February 13, 2013, 12:00 noon EST
  Waldorf Astoria Hotel
  New York, NY
   
  Citi Equities 2013 Global Healthcare Conference
  February 27, 2013, 11:05am EST
  Hilton New York
  New York, NY
   
  RBC Capital Markets Healthcare Conference
  February 27, 2013, 2:00pm EST
  New York Palace Hotel
  New York, NY

A live webcast and 30-day archive of the presentations will be available at
http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing
innovative, next-generation therapies to address unmet needs in obesity, sleep
apnea, diabetes and sexual health for U.S., Europe and other world markets.
 For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the
meaning of the Private Securities Litigation Reform Act of 1995. These
statements may be identified by the use of forward-looking words such as
"anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely,"
"may," "plan," "potential," "predict," "opportunity" and "should," among
others. There are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements. Investors should read the risk factors set forth in VIVUS' Form
10-K for the year ending December 31, 2011, and periodic reports filed with
the Securities and Exchange Commission.

CONTACT: VIVUS, Inc.
         Timothy E. Morris
         Chief Financial Officer
         morris@vivus.com

         Financial Media Relations:
         Joele Frank, Wilkinson Brimmer Katcher
         Eric Bonach
         ebonach@joelefrank.com
         212-355-4449

         Investor Relations:
         The Trout Group
         Brian Korb
         bkorb@troutgroup.com
         646-378-2923
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement